Bank of New York Mellon Corp
BankPosition in TNGX — Tango Therapeutics, Inc.
CIK 1390777
NEW YORK, NY
Position in TNGX
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$12,220,155
+$5,558,015 QoQ
Shares Held
390,920
+22.8% QoQ
Ownership
0.232%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#69
of 247 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority
Sole 87%
Shared 0%
None 13%
Common Shares in TNGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Bank of New York Mellon Corp holds $4,845,290,998 across 311 Biotechnology names. TNGX ranks #57 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,672,623 | $830,842,010 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
758,492 | $472,950,091 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
1,578,013 | $380,253,782 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
492,071 | $148,128,128 | |
| 5 | INSM |
INSMED Inc
|
1,312,756 | $139,966,036 | |
| 6 | MRNA |
Moderna, Inc.
|
1,701,675 | $119,168,293 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
601,056 | $112,565,759 | |
| 8 | INCY |
Incyte Corp
|
972,825 | $110,279,435 |
All Filings in TNGX
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,220,155 | 390,920 | Shares | Defined | 2026-08-06 | |
| 2026-03-31 | $6,662,140 | 318,458 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $3,046,420 | 343,840 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $1,615,722 | 192,348 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $962,542 | 187,997 | Shares | Defined | 2025-08-05 | |
| 2025-03-31 | $155,127 | 113,233 | Shares | Defined | 2025-04-29 | |
| 2024-12-31 | $318,330 | 103,020 | Shares | Defined | 2025-02-04 | |
| 2024-09-30 | $860,358 | 111,735 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $1,215,124 | 141,623 | Shares | Defined | 2024-07-25 | |
| 2024-03-31 | $1,002,424 | 126,250 | Shares | Defined | 2024-04-25 | |
| 2023-12-31 | $1,395,582 | 140,968 | Shares | Defined | 2024-01-29 | |
| 2023-09-30 | $1,741,617 | 154,673 | Shares | Defined | 2023-10-24 | |
| 2023-06-30 | $468,965 | 141,255 | Shares | Defined | 2023-08-03 | |
| 2023-03-31 | $558,545 | 141,404 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $1,061,044 | 146,351 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $536,469 | 148,196 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $608,759 | 134,384 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $191,175 | 25,221 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $275,917 | 25,221 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $326,107 | 25,221 | Shares | Defined | 2021-11-18 | |
| No filing history on record for this holder in this stock. | ||||||